84 related articles for article (PubMed ID: 26965858)
1. Development of a selective activity-based probe for glycosylated LIPA.
Schwaid AG; Ruangsiriluk W; Reyes AR; Cabral S; Rajamohan F; Tu M; Ward J; Carpino PA
Bioorg Med Chem Lett; 2016 Apr; 26(8):1993-6. PubMed ID: 26965858
[TBL] [Abstract][Full Text] [Related]
2. Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
Rajamohan F; Reyes AR; Ruangsiriluk W; Hoth LR; Han S; Caspers N; Tu M; Ward J; Kurumbail RG
Protein Expr Purif; 2015 Jun; 110():22-9. PubMed ID: 25620107
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of human lysosomal acid lipase and its implications in cholesteryl ester storage disease.
Rajamohan F; Reyes AR; Tu M; Nedoma NL; Hoth LR; Schwaid AG; Kurumbail RG; Ward J; Han S
J Lipid Res; 2020 Aug; 61(8):1192-1202. PubMed ID: 32482718
[TBL] [Abstract][Full Text] [Related]
4. Coronary Artery Disease-Associated
Morris GE; Braund PS; Moore JS; Samani NJ; Codd V; Webb TR
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1050-1057. PubMed ID: 28279971
[TBL] [Abstract][Full Text] [Related]
5. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.
Pullinger CR; Stock EO; Movsesyan I; Malloy MJ; Frost PH; Tripuraneni R; Quinn AG; Ishida BY; Schaefer EJ; Asztalos BF; Kane JP
J Clin Lipidol; 2015; 9(5):716-26.e1. PubMed ID: 26350820
[TBL] [Abstract][Full Text] [Related]
6. Investigation of novel chemical inhibitors of human lysosomal acid lipase: virtual screening and molecular docking studies.
Azam SS; Abbasi SW; Tahir S
Comb Chem High Throughput Screen; 2014; 17(5):473-82. PubMed ID: 24625231
[TBL] [Abstract][Full Text] [Related]
7. Systematic mutagenesis of potential glycosylation sites of lysosomal acid lipase.
Zschenker O; Bähr C; Hess UF; Ameis D
J Biochem; 2005 Mar; 137(3):387-94. PubMed ID: 15809341
[TBL] [Abstract][Full Text] [Related]
8. Deletion of sterol O-acyltransferase 2 (SOAT2) function in mice deficient in lysosomal acid lipase (LAL) dramatically reduces esterified cholesterol sequestration in the small intestine and liver.
Lopez AM; Posey KS; Turley SD
Biochem Biophys Res Commun; 2014 Nov; 454(1):162-6. PubMed ID: 25450374
[TBL] [Abstract][Full Text] [Related]
9. Impaired lysosomal acidity maintenance in acid lipase-deficient cells leads to defective autophagy.
Moriwaki T; Terawaki S; Otomo T
J Biol Chem; 2024 Mar; 300(3):105743. PubMed ID: 38354786
[TBL] [Abstract][Full Text] [Related]
10. Structure of bovine pancreatic cholesterol esterase at 1.6 A: novel structural features involved in lipase activation.
Chen JC; Miercke LJ; Krucinski J; Starr JR; Saenz G; Wang X; Spilburg CA; Lange LG; Ellsworth JL; Stroud RM
Biochemistry; 1998 Apr; 37(15):5107-17. PubMed ID: 9548741
[TBL] [Abstract][Full Text] [Related]
11. Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene.
Pisciotta L; Fresa R; Bellocchio A; Pino E; Guido V; Cantafora A; Di Rocco M; Calandra S; Bertolini S
Mol Genet Metab; 2009 Jun; 97(2):143-8. PubMed ID: 19307143
[TBL] [Abstract][Full Text] [Related]
12. Functional Characterization of LIPA (Lysosomal Acid Lipase) Variants Associated With Coronary Artery Disease.
Evans TD; Zhang X; Clark RE; Alisio A; Song E; Zhang H; Reilly MP; Stitziel NO; Razani B
Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2480-2491. PubMed ID: 31645127
[TBL] [Abstract][Full Text] [Related]
13. PRD125, a potent and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient mice.
Lopez AM; Chuang JC; Posey KS; Ohshiro T; Tomoda H; Rudel LL; Turley SD
J Pharmacol Exp Ther; 2015 Nov; 355(2):159-67. PubMed ID: 26283692
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and Cholesteryl Ester Storage Diseases.
Porto AF
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():125-32. PubMed ID: 25345094
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation of bile salt-dependent lipase (cholesterol esterase).
Mas E; Sadoulet MO; el Battari A; Lombardo D
Methods Enzymol; 1997; 284():340-53. PubMed ID: 9379944
[No Abstract] [Full Text] [Related]
16. Influence of lysosomal acid lipase polymorphisms on chromosome 10 on the risk of Alzheimer's disease and cholesterol metabolism.
von Trotha KT; Heun R; Schmitz S; Lütjohann D; Maier W; Kölsch H
Neurosci Lett; 2006 Jul; 402(3):262-6. PubMed ID: 16730122
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the mechanisms by which missense mutations in the lysosomal acid lipase gene disrupt enzymatic activity.
Vinje T; Laerdahl JK; Bjune K; Leren TP; Strøm TB
Hum Mol Genet; 2019 Sep; 28(18):3043-3052. PubMed ID: 31131398
[TBL] [Abstract][Full Text] [Related]
18. Targeting of neutral cholesterol ester hydrolase to the endoplasmic reticulum via its N-terminal sequence.
Igarashi M; Osuga J; Isshiki M; Sekiya M; Okazaki H; Takase S; Takanashi M; Ohta K; Kumagai M; Nishi M; Fujita T; Nagai R; Kadowaki T; Ishibashi S
J Lipid Res; 2010 Feb; 51(2):274-85. PubMed ID: 19592704
[TBL] [Abstract][Full Text] [Related]
19. [Acid lipases and acid cholesterol esterases: Wolman's disease and cholesteryl ester storage disease].
Nègre A; Salvayre R; Douste-Blazy L
Pathol Biol (Paris); 1988 Feb; 36(2):167-81. PubMed ID: 3279387
[TBL] [Abstract][Full Text] [Related]
20. A practical fluorometric assay method to measure lysosomal acid lipase activity in dried blood spots for the screening of cholesteryl ester storage disease and Wolman disease.
Dairaku T; Iwamoto T; Nishimura M; Endo M; Ohashi T; Eto Y
Mol Genet Metab; 2014 Feb; 111(2):193-6. PubMed ID: 24295952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
